# Ernexa Therapeutics Inc.: Form 8-K, filed Oct 5, 2023

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2023-10-05
- Accepted by EDGAR: Oct 5, 2023, 16:30 ET
- Period: 2023-10-03
- Accession: 0001140361-23-047156
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036123047156/ef20011972_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036123047156/

## Items reported

- Item 3.01: Delisting notice
- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036123047156/ef20011972_8k.htm

Filed Oct 5, 2023.
Source: SEC EDGAR, the filing index for accession 0001140361-23-047156. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.